LIPO (Lipella Pharmaceuticals Inc) Net Profit

Corporate emblem and logo of lipella.com (LIPO)

Patents and FDA approval create significant barriers to entry for competitors in the orphan drug niche for Lipella Pharmaceuticals (LIPO). The company's financial profits visualize these advantages, where 0.00 is recorded as the baseline value. Growth is supported by innovations in local bladder treatment, although micro-cap status and resource deficits among management limit overall asset management transparency.

LIPO (Lipella Pharmaceuticals, Inc.) Company Net Income history from 04/28/2023 to 07/19/2025

Financial and market metric breakdowns for Lipella Pharmaceuticals, Inc. (LIPO)

- price and consensus price forecast:
Stock Quotes Lipella Pharma|LIPO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Lipella Pharma|LIPO - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Lipella Pharmaceuticals|LIPO - Company Book Value|Market-to-Book Ratio lipella.com|LIPO - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Lipella Pharmaceuticals|LIPO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Lipella Pharmaceuticals Inc|LIPO - Company Aggregate Debts|Debts to Book Value Lipella Pharma|LIPO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Lipella Pharmaceuticals|Quick Liquidity lipella.com
- net income and valuation multiples indicators:
LIPO - Net Profit
Fundamental valuation:LIPO Lipella Pharma
Flagship merchandise of Lipella Pharmaceuticals Inc

This indicator calculates the daily net profit of Lipella Pharmaceuticals (LIPO) in real time, transforming market data into projected cash flow to assess future returns. The automation of biopharmaceutical research through robotics optimizes personnel costs, which is directly reflected in the company's net income trends, confirming the efficiency of the operating model on this chart.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Company Net Income Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc - Company Net Income|scPharma - Net Profit|Net Financial Result Tectonic Therapeutic, Inc. TECX|Tonix Pharmaceuticals (TNXP) - Company Net Income|Profit After Tax SXTC (China SXT Pharmaceuticals, Inc.)|EPRX (Eupraxia Pharmaceuticals, Inc.) - Net Profit|Company Net Income BioHarvest Sciences, Inc. BHST|Company Net Income Invizyne Technologies, Inc. (EXOZ)|Company Net Income ORMP (oramed.com)|Company Net Income Entera Bio ENTX|ipatherapeutics.com - Company Net Income|ABVC BioPharma, Inc. - Net Profit|CPIX - Net Profit|QNTM (Quantum BioPharma Limited) - Net Income|FibroGen Corporation - Final Profit|Company Net Income Telomir Pharmaceuticals|Rani Therapeutics Inc - Profit After Tax|Net Profit SNYR|RLYB (rallybio.com) - Final Profit|Net Profit LEXX (Lexaria Bioscience Corp.)|Net Profit Pulmatrix Corporation PULM|PTHL - Company Net Income|Final Profit APM (Aptorum Group Limited)|Lyra Therapeutics (LYRA) - Company Net Income|Net Income impactbiomedinc.com|TNFA (TNF Pharmaceuticals Inc.) - Net Profit|Net Profit cbdMD Corp|Net Profit PRFX|Net Income altamiratherapeutics.com CYTO|Net Profit OPTN (OptiNose)|Pieris Pharmaceuticals Inc (PIRS) - Company Net Income|PROC: Net Income|PTPI - Net Profit|QLI (Qilian International) - Net Income|SLRN: Profit After Payment of Taxes|TFFP (TFF Pharmaceuticals, Inc.) - Net Profit